General MedicationsINTRAUTERINEGeneric
CU-7
COPPER
Standard Dose
89MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview CU-7 is listed in Drugs@FDA under application 017408 (NDA).
Marketing status: Discontinued Active ingredient COPPER Form and strength INTRAUTERINE DEVICE;INTRAUTERINE - 89MG Sponsor GD SEARLE LLC Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview CU-7 is listed in Drugs@FDA under application 017408 (NDA). Marketing status: Discontinued Active ingredient COPPER Form and strength INTRAUTERINE DEVICE;INTRAUTERINE - 89MG Sponsor GD SEARLE LLC Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.